Dow Jones' Pfizer is making a big push into gene therapy manufacturing as it tackles Duchenne muscular dystrophy and hemophilia B, rivaling Sarepta Therapeutics and Spark Therapeutics.

source https://finance.yahoo.com/m/bbe7efa9-a267-3d33-98f6-51dd83375f3f/gene-therapy-battle-heats%3A.html?.tsrc=rss